Cumberland Pharmaceuticals CPIX Payments to Acquire Other Investments

Payments to Acquire Other Investments at other companies

JAK

Jakks PacificJAKK

$223K-77.6%

Lincoln NationalLNC

$417M+5.0%

American Coastal Insurance CorporationACIC

$79K-32.5%

Community Health SystemsCYH

$42M+90.9%

The Baldwin Insurance Group, Inc.BWIN

$87K-86.0%

Employers HoldingsEIG

$1.2M-73.8%

Other financials

Income statement

See full

Revenue$9.1M-22.0%

Gross profit$7.2M-30.0%

Operating income-$3.1M-342%

Net income-$3.3M-362%

EPS (diluted)-$0.22-375%

Balance sheet

See full

Cash & equivalents$11.0M-27.1%

Total debt$4.8M-7.1%

Total equity$21.6M-24.5%

Total assets$71.0M+1.5%

Cash flow

See full

Operating cash flow$387.0K-90.1%

CapEx--100%

Free cash flow$387.0K-89.9%

Valuation

See full

Market cap$97.09M+138%

Enterprise value$90.91M+207%

P/S2.3×+1.3×

Profitability

See full

Gross margin82.9%-1.4pp

Operating margin-17.2%-125pp

Net margin-17.6%-103pp

FCF margin3.3%—

Returns & leverage

See full

Return on equity-29.4%-86.3pp

Debt / equity0.2×0.0×

Current ratio1×-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireOtherInvestments.

The official record: Cumberland Pharmaceuticals’s 10-K, filed March 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's payments to acquire other investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cumberland Pharmaceuticals's payments to acquire other investments?: Cumberland Pharmaceuticals (CPIX) reported payments to acquire other investments of $500K in Q4 2025.